Objective
Biotechnology startup Altratech Ltd was founded with the vision to transform molecular diagnostics through nanotechnology. We
have developed and patented a novel technology for molecular testing of viruses and pathogens in non-clinical environments. This
all-synthetic novel assay can detect and quantify DNA, RNA, Antibody, and Antigen molecular targets, from blood or saliva samples, in
20 mins, without any need of centrifuges or pipettes. This will enable market-disrupting products that have the simplicity of a
pregnancy test and the performance of a laboratory PCR test.
All molecular diagnostic systems today require biological amplification, i.e. polymerase chain reaction (PCR), Loop-mediated
polymerase amplification (LAMP), or similar. This takes time, and requires trained personnel, refrigeration for enzymes, and specialised
equipment for heating/cooling and optical detection. It is because of these requirements that there is no solution on the market
today for the non-clinical detection, monitoring, and management of viral infections such as HIV, Hepatitis, Influenza, Malaria,
Meningitis, Shingles, Dengue Fever, HPV, EBV-related cancers, and many more.
Our solution is a molecular detection process that eliminates the requirement for biological amplification and optical detection. We
have invented and patented the key breakthrough of detecting and quantifying genetic material, viruses, and pathogens using
almost instant electronic signal amplification, with semiconductor sensing and digital readout.
The Value Proposition to our target customers, who will be the worlds leading diagnostic companies, is the ability to licence a novel
patent protected product, with a wider range of market applications compared to their current diagnostic products. This will
facilitate their entry into new markets and increase gross margins in existing markets.
This innovation will impact the 48B Diagnostics industry.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences health sciences infectious diseases malaria
- engineering and technology nanotechnology
- medical and health sciences health sciences infectious diseases RNA viruses influenza
- medical and health sciences health sciences infectious diseases RNA viruses HIV
- engineering and technology medical engineering medical laboratory technology laboratory samples analysis
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
HORIZON.3.1 - The European Innovation Council (EIC)
MAIN PROGRAMME
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
HORIZON-EIC-ACC - HORIZON EIC Accelerator
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) HORIZON-EIC-2024-ACCELERATOR-02
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
V94 AT85 Limerick
Ireland
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.